Thyroid cancer (TC) is the most common endocrine malignancy and in most countries,
incidence rates are increasing. Although differences in population iodine intake are a …

Thyroid cancer (TC) is the most frequent endocrine malignancy. The incidence of TC,
especially papillary thyroid carcinoma (PTC), has continued to rise all over the world during …

Abstract BRAF V600E mutation, RET rearrangements, and RAS mutations are the common
genetic alterations in differentiated thyroid carcinomas derived from follicular thyroid cells …

Most epidemiological studies concerning differentiated thyroid cancers (DTC) indicate an
increasing incidence over the last two decades. This increase might be partially explained …

Abstract Background The BRAFV600E mutation is valuable for the diagnosis, prognosis,
and therapy of papillary thyroid cancer (PTC). However, studies related to this mutation have …

Background: Excess iodine inhibits thyroid follicular cell proliferation associated with TGFβ
pathway activation, although thyroid cancers are frequently refractory to TGFβ signaling. The …

As proteomics technologies develop, increasing number of membrane-associated proteins
specific for cancer cells are being discovered. These proteins are of great interest …

Thyroid cancer is the most common endocrine cancer with predominant prevalence of
papillary thyroid cancer (PTC) histotype. MAPK signaling genetic alterations are frequent in …

BACKGROUND Evidence indicates that iodine per se could be implicated in the physiology
of several organs that can internalize it. In thyroid and breast cancer, iodine treatments …

Iodide has direct effects on thyroid function. Several iodinated lipids are biosynthesized by
the thyroid and they were postulated as intermediaries in the action of iodide. Among them …